What caused the Abbott glucose sensor recall?

Manufacturing problem, patient risks, and immediate steps

A manufacturing defect in millions of glucose sensors made by Abbott prompted regulators and the company to recall affected devices after the fault was linked to serious patient harm, including at least seven deaths and hundreds of injuries reported worldwide. The defect reportedly can cause inaccurate glucose readings or device failures that leave users without reliable continuous‑glucose monitoring (CGM) information they depend on to dose insulin and manage hypoglycaemia.

Why the defect is dangerous

• CGM users often rely on sensor glucose values and alarms to make immediate treatment decisions. False low or false high readings can lead to missed hypoglycaemia or inappropriate insulin dosing, both of which can be life‑threatening.
• Alarm failures or sudden sensor loss of signal remove a safety net for people with type 1 and insulin‑treated type 2 diabetes.

Practical steps for patients and clinicians

• Check whether a specific lot or model has been listed in the company or regulatory recall postings and register devices for recall notifications.
• Verify suspicious or unexpected CGM readings with a capillary fingerstick blood glucose test before adjusting insulin doses.
• Report any device issues or adverse health events to the manufacturer and to the national medical device reporting system.
• Clinicians should proactively contact patients who use CGMs, review alternative monitoring strategies and consider temporary reliance on fingerstick testing until affected sensors are replaced.

Officials have not publicly detailed exactly how the manufacturing fault occurred or which production sites were implicated. Abbott and regulators are expected to provide further information about affected serial numbers, replacement procedures and any recommended clinical follow‑up as the recall response continues.